Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations for human and animal healthcare in India and internationally. It offers injectable critical care solutions, anti-infectives, antifungals, anti-ulcer therapies, oncology support, cardiovascular therapies, and women's healthcare solutions such as gonadotropins, hormonal therapies, and haematinic formulations. Th...
Lyka Labs Limited is currently fairly valued (P/E: N/A). The stock has pulled back today.